FDA’s lab-developed test rule could be first test of agency’s power post-Chevron

The recent U.S. Supreme Court decision to overturn the Chevron doctrine could open the door to more challenges of Food and Drug Administration regulations, including the agency’s controversial rule on lab-developed tests.